The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MRI targeted biopsy dramatically increases detection of clinically significant prostate cancer while reducing the risk of indolent cancer detection.
 
Michael Ahdoot
No Relationships to Disclose
 
Amir H Lebastchi
No Relationships to Disclose
 
Sandeep Gharam
No Relationships to Disclose
 
Patrick H Gomella
No Relationships to Disclose
 
Jonathan Bloom
No Relationships to Disclose
 
Graham Hale
No Relationships to Disclose
 
Samuel A Gold
No Relationships to Disclose
 
Baris Turkbey
No Relationships to Disclose
 
Peter A. Pinto
No Relationships to Disclose
 
Thomas Sanford
No Relationships to Disclose
 
Peter L. Choyke
Patents, Royalties, Other Intellectual Property - I am a patent holder for MRI-Ultrasound fusion technology licensed to InVivo which markets it as UroNav. However, as a government employee I personally receive no financial benefit from this patent.
Other Relationship - Aspyrian Therapeutics; GE Healthcare; Philips Healthcare
 
Howard L. Parnes
Stock and Other Ownership Interests - 3M; Danaher; Editas Medicine; FLir; Fortive; Foundation Medicine; General Electric; Gilead Sciences; Health Care Select Sector; Henry Schein; Illumina; Intellia Therapeutics; Intuitive Surgical; Johnson & Johnson; Novartis; Quintiles; Roche; Roper Technologies; Schlumberger; Sigma-Aldrich; SPDR S and P Biotech ETF; Varian Medical Systems